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Summary 
To reconstitute the human immune system in mice, transgenic mice expressing  human CD4 
and human major histocompatibility  complex (MHC) class II (DQw6) molecules in an endogenous 
CD4- and CD8-deficient background (mCD4/8-/-),  after homologous recombination, have 
been generated.  We  report  that expression of human CD4  molecule in  mCD4/8 -/-  mice 
rescues thymocyte development and completely restores the T cell compartment in peripheral 
lymphoid organs.  Upon vesicular  stomatitis virus (VSV) challenge,  the reconstituted mature 
T cell population effectively provide T help to B cells in immunoglobulin class switching from 
IgM to specific IgG-neutralizing antibodies.  Human CD4 +  DQw6 + double transgenic mice are 
tolerant to DQw6 and the DQw6 molecule functions in antigen presentation, effectively  generating 
a human MHC class II-restricted T  cell response to streptococcal  M6C2 peptide. These data 
show that both the hCD4 and DQw6 molecules are functional in mCD4/8-/-  mice, fully and 
stably reconstituting this limb of the human immune system in mice. This animal model provides 
a powerful in vivo tool to dissect the human CD4-human class II MHC interaction, especially 
its role in human autoimmune diseases, superantigen-mediated diseases, and acquired immuno- 
deficiency syndrome (AIDS). 
S 
urface expression of the CD4 or CD8 glycoprotein dis- 
tinguishes the helper and cytotoxic subsets of T lympho- 
cytes, respectively. CD4 is a member of the immunoglob- 
ulin gene superfamily, involved in recognition of MHC class 
II molecules on the surface of antigen presenting cells by T 
lymphocytes (1). The interaction between CD4 and MHC 
class II molecules is known to be an important event in both 
T  cell ontogeny and peripheral activation of helper T  cells 
(2-4). Extracellularly, CD4 interacts with MHC class II mol- 
ecules via the MHC 3  chain (5) which contributes to the 
species barrier in the interaction between CD4 and class II 
MHC. Despite this species barrier,  human CD4 molecules 
have been shown to function as coreceptors in mice, though 
less efficiently than murine CD4 (6, 7). Intracellularly,  CD4 
is  associated  with  the  src  family protein  tyrosine kinase 
p561ok (8), which has been shown to be essential for antigen 
receptor-mediated signaling (9, 10) and T cell development 
(11). The cytoplasmic domain of CD4 is highly conserved 
across mammalian species with  79%  homology between 
human and mouse sequences, but an overall homology of 
only 55% exists between human and mouse extracellular and 
transmembrane regions (12). The human CD4 molecule has 
been shown to be the principal cellular receptor for HIV (13). 
The external envelope glycoprotein of HIV, gp120, binds with 
high affinity to CD4, and is the prime determinant of HIV 
tropism, facilitating the binding and penetration of viral par- 
ticles, which is central  to the cytopathic process. Mice are 
not susceptible to HIV infection and the mouse CD4 mole- 
cule, L3T4, does not bind gp120  (14). 
The family of MHC class II molecules is encoded on chro- 
mosome 17 in the mouse and chromosome  6 in humans. Four 
murine class II polypeptides Aot and A3, or Eot and E/3 pair 
to form I-A and I-E heterodimers on the cell surface, respec- 
tively. The human MHC class II locus contains the genes 
encoding the ot and 3  chains for HLA-DR, DQ,  and DP 
molecules, as well as, the DO and DZ genes, whose function 
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and I-E molecules are DQ and DR, respectively. The DO 
and DZ mouse counterparts are AB2 and E/~2 whose expres- 
sion differs from that of classical I-A and I-E molecules (16, 
17).  Besides the role of HLA-DQ molecules in restricting 
T cell responses, many DQ alleles have generated interest be- 
cause of their strong association with autoimmune diseases 
such as type I diabetes, coeliac disease, and multiple sclerosis 
(18). It is interesting to note that HLA-DQ-restricted cells 
may play a  unique role in  the immune response to  some 
pathogens. Thus, in the general population there are geneti- 
caUy determined responders and nonresponders to streptococcal 
cell wall antigen,  and non~esponsiveness can be abrogated 
by  monoclonal  antibodies  to  DQ,  suggesting  an  im- 
munoregulatory role provided by the DQ molecules (19, 20). 
The purpose of the present study was to investigate the 
specific interaction between human CD4 and human MHC 
class II (DQw6), in an in vivo system. The endogenous CD4- 
and  CD8-deficient  mouse  strain  (mCD4/8-/-) 1 was  an 
ideal model system to use, as crossspecies  molecular interac- 
tions  are minimized.  Reconstitution of the entire human 
CD4-MHC  class  II  arm  of the  immune  system  in  this 
knockout mouse, optimized the expression and function of 
the human CD4 molecule in this model. We provide evi- 
dence for full restoration of phenotype and function by both 
human transgenes and effective interaction between hCD4 
and DQw6 in generating an immune response. This unique 
system provides a valuable in vivo model to evaluate the im- 
portance of human CD4-MHC class II interactions in the 
pathogenesis of human diseases including autoimmune dis- 
eases,  superantigen-mediated diseases,  and AIDS. 
Materials and Methods 
Mouse Strains.  C57BL/6 and BALB/c  mice were purchased from 
The Jackson Laboratory (Bar Harbor, ME). Mice homozygous for 
the routine CD4 and CD8 mutations  have been described (21). 
Briefly, using the method of targeted gene disruption and homo- 
logous  recombination  in  embryonic  stem  cells, mouse  strains 
carrying  mutations  in  the Lyt-2 (CDSo~) gene  (22) and L3T4 
(CD4) gene (4) were bred together until homozygous  for both 
mutations  (mCD4/8 -/-  double  knockout).  The human  CD4 
transgenic  mice (line 313, described in reference 23),  with the 
CD4 transgene expressed  under the control of the CD2 expression 
cassette (24), have lymphocyte-specific, copy number-dependent, 
integration  site-independent  expression of human  CD4.  These 
hCD4 transgenic  mice were bred into the mCD4/8 -/-  double 
knockout mice. Concurrently,  the human MHC class II DQw6 
transgenic mice (19), with coinjected DQw6 o~ and/3 genomic 
1 Abbreviations used in  this paper: BME, /3 mercaptoethanol; DQw6  + 
mCD4/8-/- mice, mice  expressing  human DQw6 transgene in an endo- 
genous murine CD4- and CD8-deficient  background; hCD4+DQw6§ 
mCD4/8-/-  mice, mice expressing human CD4 and human DQw6 
transgenes in an endogenous  murine  CD4- and CD8-deficient  background; 
hCD4+mCD4/8 -/-  mice, mice expressing human CD4 in an endo- 
genous mouse CD4- and CDS-deficient  background; mCD4/8-/-, mice 
with targeted  gene  disruption in both endogenous  CD4 and CD8; MLR, 
mixed lymphocyte  reaction; SCW, streptococcal  cell wall; VSV, vesicular 
stomatitis virus. 
DNA fragments under control of their endogenous promoters, 
were bred into the mCD4/8-/- background.  These two strains 
of mutant  mice were  then  bred  together to obtain  hCD4 § 
DQw6+/-mCD4/8 -/- double transgenic, double knockout mice. 
Mice were typed by FACS  |  (Becton Dickinson & Co., Mountain 
View, CA) of PBL as described below. All mice used in the ex- 
periments had an H-2  b background  unless otherwise  stated. All 
animals were cared for in accordance with regulations under "The 
Animals for Research Act 1980" and the regulations of the On- 
tario Cancer Institute  Animal Care Committee. 
Immunofluorescence.  Blood samples (20 #1) were collected in 
heparinized capillary tubes, washed once in immunofluorescence 
staining buffer (Ca  2+ and Mg  2+ free PBS, 0.1% NAN3, 5% FCS), 
and double stained with PE-conjugated anti-human CD4 (Leu3a; 
Becton Dickinson  & Co.) and FITC-conjugated  anti-HLA  DQ 
(Leul0;  Becton  Dickinson  &  Co.),  anti-human  CD4-PE,  and 
anti-mouse CD3-FITC (145-2Cll, PharMingen, San Diego, CA), 
or anti-mouse L3T4-PE (Becton Dickinson & Co.) and anti-mouse 
Lyt-2-FITC (Becton Dickinson & Co.).  Additionally, PBL from 
mCD4 -/-  single  knockout  mice  were  triple  stained  with 
anti-human CD4 (Leu-3a-PE), anti-mouse Thy 1.2-FITC (Becton 
Dickinson & Co.), and anti-mouse Lyt-2 Biotin (Becton Dickinson 
& Co.) which was visualized using Streptavidin Red 670 (GIBCO 
BRL, Gaithersburg, MD). Single cell suspensions of  thymuses from 
8-12-wk-old mice were resuspended in staining buffer and stained 
with anti-mouse TCR-a//3 FITC (PharMingen). Similarly lymph 
node cells (mesenteric, inguinal, and paraaortic) from 8-12-wk-old 
mice were resuspended in staining buffer and incubated (4~  with 
appropriate antibodies. Samples were analyzed using a FACScan  | 
(Becton Dickinson  & Co.). 
Mixed Lymphocyte Reaction (MLR).  Purified  spleen  cell responders 
(10  s and 3  x  10  s) were cocultured with 106 irradiated (2,000 tad) 
splenic stimulator cells in 200 #1 of IMDM supplemented with 
10% heat inactivated FCS (Hyclone Laboratories  Inc., Logan, UT), 
B mercaptoethanol (/~ME, 5  x  10 -s M), 0.01% penicillin, and 
streptomycin  in 96-well flat-bottomed plates (Nunc, Koskilde, Den- 
mark).  After 3,  5,  7,  and  10 d of incubation  at 37~  and 5% 
CO2, cells were pulsed for 16 h with 1 #Ci of [3H]thymidine. For 
antibody blocking studies, purified anti-DQ mAb (Chemicon In- 
ternational Inc., Temecula, CA) or anti-I-A  b mAb (PharMingen) 
were dialyzed using microcollodion  bags (Sartorius AG, Gottingen, 
Germany) as per protocol Both mAb were added to irradiated 
splenic stimulator cells at a concentration of 0.1-10 #g/ml and in- 
cubated at 37~  for 1 h before addition  of purified spleen cell 
responders. After 5 d of incubation, cells were pulsed for 16 h with 
1/~Ci of [3H]thymidine. 
T CelIProliferation Assay.  Experimental mice were immunized 
with 20 #g of soluble M6C2 peptide emulsified in 200 #1 of com- 
plete Freund's adjuvant (CFA) at the base of the tail (100 #1 per 
side). M6C2 is a 21-met (AKKQVEKDLANLTAELDKVKE) de- 
rived from Streptococcal cell wall (SCW) extract from rheumato- 
genic strains of Streptococci. Inguinal and paraaortic lymph nodes 
were harvested after 9-12 d and single cell suspensions were pre- 
pared in 5 ml of RPMI 1640 media supplemented with 10% heat- 
inactivated FCS (Hyclone Laboratories Inc.), 100 U/ml penicillin, 
100 #l/ml streptomycin, 2 mM L-glutamine, 50 #M/~ME,  and 
20 mM Hepes. T cell enrichment  was accomplished via passage 
of single cell suspensions through T cell enrichment columns (R 
& D Systems, Inc., Minneapolis, MN) according to protocol. The 
enriched T cells (4  x  10  s) were cultured in 200 #1 of complete 
medium (as described above), in triplicate in 96-well flat-bottomed 
tissue culture plates (Nunc), containing 8  x  10  s irradiated (3,000 
rad) syngeneic spleen cells as APC, with or without peptide, at 
1912  Human  CD4-MHC Class II Transgenic Mice 37~  in a humidified atmosphere containing  5% CO2 for 48 h 
and pulsed with  1/zCi  [3H]thymidine for an additional  12 h. 
Detection of Neutralizing Serum Antibodies to Vesicular Stomatitis 
Virus (VSV).  VSV Indiana (isolate P3) was obtained from Dr. Lud 
Prevec (McMaster University, Hamilton, Ontario, Canada). Seeds 
were grown on BHK 21 cells infected with low multiplicity of 
infection and plaqued on Veto cells.  The determination of neu- 
tralizing anti-VSV serum antibody titers has been described previ- 
ously (25).  Briefly, sera were prediluted 80-fold in minimal essen- 
tial medium, then heat inactivated for 30 rain at 56~  Twofold 
serial dilutions were mixed with equal volumes of virus containing 
300 PFU/ml. The mixture was incubated for 90 rain at 37~  100 
#1  of this  serum virus  mixture  was  transferred  onto  Veto  cell 
monolayers in 96-weU plates and incubated for 1 h at 37~  The 
monolayers were then overlaid with 100 #1 DME containing 1% 
methylcellulose. After incubation for 24 h at 37~  the overlay was 
flicked off and the monolayer was fixed  and stained with crystal 
violet in formaldehyde. The highest dilution of serum that reduced 
the number of plaques by 50% was taken as the titer. To determine 
IgG titers undiluted  sera were pretreated with an equal volume 
of 0.1  M  3ME in  saline  (26). 
Cytotoxicity Assays.  VSV-specific cytotoxicity was determined 
in a standard  primary SlCr release assay (27, 28). Briefly, mice were 
immunized intravenously with 2  x  106 PFU of VSV. After 6 d 
spleen cells were coincubated for 5 h with SlCr-labeled target cells. 
C57BV6 
oJ  o.i 
91.38~. 
M~  I 
1  ~_o. 
~60  '  .....  i~l  "  .....  i~2  ......  i?~' ......  il~ 
8.67% 
I 
VSV-specific cytotoxicity was measured on MC57G (H-2  b) fibro- 
blasts infected with VSV. Noninfected MC57G ceils were used as 
controls.  Spontaneous  release  was <15%  in all assays. 
Histology.  Thymuses of 8-12-wk-old mice were harvested and 
fixed in 10% formalin. All tissues were sectioned serially at different 
levels and conventionally stained with hematoxylin and eosin. 
98.07% 
Results 
Human  CO4  Rescues  Thymocyte  Development.  Mice 
deficient in both CD4 and CD8 expression (21) have normal 
total number of thymocytes, but a marked reduction of ma- 
ture TCtL-od/~his h thymocytes. In accordance with a block 
in thymocyte maturation,  the size of the thymic medulla is 
largely  diminished  on  histologic  sections.  To  investigate 
whether the introduction  of the human CD4 molecule into 
mCD4/8 -/-  mice  could  restore  thymocyte  maturation, 
thymocyte populations of 8-12-wk-old mice were analyzed 
by flow cytometry with the use of various monoclonal anti- 
bodies as described in Materials and Methods.  Introduction 
of the human CD4 transgene, alone and in combination with 
HLA-DQw6,  rescued T  cell development and restored the 
thymic  population  corresponding  to  TCl~-o//~ high HSA- 
mCD4/8-/- 
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Figure  1.  TCK-ed3 expression on thymo- 
cytes. Single cell suspensions of thymuses from 
8-12-wk-old mice were prepared and stained 
with  anti-TCR-oz/3  FITC  as  described in 
Materials and Methods. Figure  2.  Thymic sections of (A) hCD4+/-DQw6+/-mCD4/8  -/-, 
(B)  hCD4+/-mCD4/8 -/-,  (C)  C57BL/6,  (D)  mCD4/8 -/-,  (E) 
DQw6 +/- mCD4/8-/- mice. The thymus was removed  from 8-12-wk- 
old mice, fixed in 10% formalin, sliced, and stained with hematoxylin 
and eosin. 
(Jlld-)  mature  thymocytes (Fig.  1).  Moreover,  these mice 
showed a dramatic increase in medullary size and the appear- 
ance of numerous Hassell's corpuscles on serial histologic sec- 
tions  (Fig.  2). 
In peripheral lymphatic organs the T  cell population was 
also rescued with the lymph node T cell population increasing 
from  10 to 20%  in double knockout mice to  70%  (wild- 
type levels) in mice expressing the hCD4 transgene (Fig. 3). 
A  similar  increase in  the peripheral  T  cell population  was 
seen in the spleen (data not shown).  The decreased level of 
TCR/CD3  expression on peripheral  T  cells from mCD4/ 
8 -/-  mice  previously  observed  (21)  was  also  restored  to 
normal levels in the presence of hCD4 (data not shown). It 
should be noted that  the presence of the DQw6 molecule 
alone in  the CD4-  and  CDS-deficient background  had no 
effect in restoring  the mature TCR-o~/fl  h~gh T  cell popula- 
tion within  the thymus  (Fig.  2) or in restoring  peripheral 
T  cell  populations. 
Increased hCD4 Expression on T Cells in the Absence of  mCD4 
and mCD8.  The expression of hCD4 on T  cells varied de- 
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Figure 3.  Rescue of the mature peripheral  T  lymphocyte population 
by the human CD4 transgene. Single cell suspensions were made from 
mesenteric, paraaortic, and inguinal lymph nodes and stained with anti- 
CD3 FITC and anti-human CD4-PE, as described in Materials and 
Methods. Please note in upper  panels, human CD4 expression on B lym- 
phocytes, as CD2 expression  cassette drives expression of human CD4 at 
low levels in B cells. 
pending  on the presence or absence of mCD4  alone or in 
combination with mCD8  (Fig.  4, A  and B).  The level of 
hCD4 expression in normal C57BL/6 mice was much lower 
compared with that in human peripheral blood lymphocytes. 
T  lymphocytes with deficient mCD4 had an increased level 
of expression of hCD4. This increase was even more dramatic 
in the mCD4/8 -/-  double knockout mice (Fig.  4 A). It is 
interesting  to note that  the expression of the hCD4 trans- 
gene in mCD4-/-  mice varied depending on whether the 
T  cells expressed endogenous CD8  or not.  In the absence 
of mCD8, hCD4 expression level was much higher than in 
T cells coexpressing the endogenous mCD8 (Fig. 4 B). The 
high level of hCD4 expression on the double knockout T 
cells were comparable (70% of the mean fluorescent inten- 
sity) to that on human PBL (Fig.  4 A). The hCD4 expres- 
sion remained stable in these transgenic knockout mice studied 
up to the age of 18 mo  (data not  shown). 
Human CD4 Restores T Help for B  Cells.  We previously 
reported that T help for B cells is markedly reduced but not 
completely absent in mice without  CD4 alone (29),  or in 
mice without both CD4 and CD8 molecules (21).  This T 
help is provided by CD4/CD8 double negative TCR-ot/3 + 
T cells, which are restricted to class II MHC molecules (29). 
To test whether the human CD4 molecule could restore T 
helper cell functions to normal levels, hCD4 +  mCD4/8-/- 
mice  were  compared  with  mCD4/8 -/-  mice  and 
hCD4+mCD4 -/-  mice compared with mCD4 -/-  for their 
efficiency in immunoglobulin class switching after VSV chal- 
lenge.  The  neutralizing  IgM response which peaks at  day 
4 after immunization is independent of T help (30, 31), and 
comparable titers were reached in all groups of mice tested 
(Fig. 5), confirming that all mice were adequately immunized. 
The immunoglobulin class switch from IgM to neutralizing 
IgG is strictly dependent  on T  help  (30,  31).  As reported 
previously, IgG class  switching  in mCD4/8-/-  mice was 
more efficient than  in mCD4-/-  mice most likely due to 
the higher numbers of double negative T cells in the double 
knock out mice (21). However, in both groups of mice the 
human CD4 transgene fully restored T help for B cells back 
to  normal  levels  when  compared with mCD4 +/+  control 
mice (Fig.  5). 
Human CD4 Restores  T  Help for CTL.  The generation 
of VSV-specific CTL responses depends on T help (32).  We 
therefore investigated the ability of the human CD4 mole- 
cule to restore T help for CTL in hCD4+/-mCD4 -/-  mice 
compared with mCD4-/-  single knockout mice.  Mice were 
immunized  intravenously with VSV on day 0 and primary 
VSV-specific cytotoxicity was assessed on day 6. Fig. 6 shows 
that the presence of the human CD4 transgene increased cyto- 
toxic  T  cell  activity by a  factor  of 3  and  cytotoxicity in 
hCD4 +/- mCD4-/-  mice was  comparable  to  mCD4 +  / + 
controls. 
Acquisition  of Immunologic  Tolerance to DQw6.  During 
thymic ontogeny, developing T lymphocytes undergo posi- 
tive selection for self-MHC restriction,  and clonal deletion 
to eliminate thymocytes expressing self-reactive T cell receptors. 
To study whether T  cells developing in DQw6 transgenic 
mice are tolerant against the human MHC class II molecules, 
peripheral T lymphocytes were isolated and stimulated with 
irradiated  splenic stimulator  cells expressing DQw6 mole- 
cules. Elimination  of self-reactive T  cells was evidenced by 
the lack of stimulation by DQw6 + splenic stimulators when 
cocultured with T responders from hCD4 +DQw6 § mCD4/ 
8-/-b/b  mice.  In  contrast,  T  cells  from  hCD4+mCD4/ 
8-/-b/b  littermate controls responded readily to the same 
DQw6 stimuli. Both groups were tolerant to cells from the 
H-2  b background and to the human CD4 molecule (Fig.  7 
A), but responded vigorously to allogeneic H-2  k stimulators 
(data  not  shown).  It  should  be  noted  that  T  cells  from 
mCD4+mCDS-b/b  and  C57BL/6  mice  also  responded 
to DQw6 positive APCs  (data  not  shown).  T  cells  from 
DQw6§  mice did not respond to DQw6 
positive stimulators,  and their littermate controls,  mCD4/ 
8-/-b/b mice demonstrated only a weak response to DQw6 
stimulation (data not shown). T cells from mice lacking both 
CD4 and CD8 molecules have previously been reported to 
have only very weak alloresponsiveness  (21). Anti-DQ mono- 
clonal  antibodies  specifically  blocked  the  hCD4 +mCD4/ 
8-/-b/b T cell proliferative  response to DQw6 + stimulators 
in a dose-dependent fashion, but anti-I-A  b monoclonal an- 
tibodies were not inhibitory  (Fig.  7 B). A  time course on 
the MLR using all the mouse strains described above showed 
maximal response to DQw6 at day 7 and no difference in 
kinetics of response between all of the mouse strains tested 
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Figure  4.  Human  CD4  expression  on  T 
cells from PBL. Peripheral blood samples were 
obtained from tail vein venipuncture in mice, 
and from capillary samples from healthy human 
volunteers. Histograms depict fluorescence in- 
tensity  staining  with  human  CD4-PE  and 
numbers represent mean fluorescence intensity. 
(A) PBL were stained with anti-human CD4- 
PE as described in Materials and Methods. Rep- 
resentative histograms from individual mice are 
shown as fluorescence intensity of human CD4- 
PE staining. (B) PBL from hCD4+mCD4 -/- 
mice  were  triple  stained  with  anti-Thy  1.2 
FITC, anti-Lyt2 Biotin plus streptavidin RED 
670, and anti-human CD4-PE as described in 
Materials and Methods. Histograms showing 
human CD4-PE fluorescence intensity for the 
following lymphocyte subsets were obtained 
by gating on the appropriate cell populations 
on the contour graph in the upper left panel: 
CD8 +  T  cells,  gate  R.3  (Thy  1.2 §  Lyt2+), 
CDS-  T  cells,  gate R2 (Thy 1.2 + Lyt2-), B 
lymphocytes,  gate g4  (Thy  1.2-  Lyt2-). A  B  A 
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Figure  5.  Neutralizing antibody response to VSV. Mice were immunized 
intravenously with VSV (2  x  106 pfu) on day 0. After 4 d, neutralizing 
IgM titers were determined. Neutralizing IgG titers were measured after 
8 and 20 d. The values shown represent the number of twofold dilution 
steps starting at a predilution of 1/80.  (A) hCD4+/-mCD4 -/-  (open 
circle); mCD4 -/-  (solid triangle); mCD4 §  (mCD8 +/+) (solid diamond). 
(B)  hCD4 §  mCD4/8 -/-  (open circle); mCD4/8 -/-  (solid triangle); 
mCD4 +/+  (mCD8 +/+) (solid diamond). 
(data  not  shown).  Response  to H-2  k stimulation showed 
similar kinetics between all mouse strains but peaked at day 5. 
DQw6-restricted Antigen  Presentation.  To study whether 
DQw6-restricted T cell responses can be generated in this 
double transgenic knockout system, the T cell proliferative 
response to antigen presentation by the human MHC class 
II molecule was studied.  Previously it has been shown that 
the mouse I-A  b molecule does not effectively  present M6C2, 
a 21-met peptide found in SCW extract from rheumatogenic 
strains of Streptococcus (33). By contrast, the same peptide 
is presented by the human DQw6 molecule but not by other 
human DQ molecules  such  as DQw4  (33). T  cells from 
hCD4 +DQw6 §  mice,  demonstrated  a 
marked proliferative  response to M6C2 peptide when presented 
by autologous splenocytes, throughout varying concentra- 
tions  (Fig. 8).  Conversely, in the absence of DQw6 + an- 
tigen presenting cells, T cells from the hCD4 +  mCD4/8-/- 
H-2  b single transgenic littermates did not respond to M6C2 
peptide (Fig. 8). This response is specific to DQw6 as the 
DQw4 molecule is unable to elicit the same T cell response 
in the presence of M6C2 peptide  (33). It should be noted 
that T  cells from DQw6+mCD4/8 -/-  single  transgenic 
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Figure  6.  Primary  CTL  re- 
sponses against VSV.  Mice were 
infected intravenously with 2  ￿ 
106 pfu of VSV.  After 6  d,  pri- 
mary cytotoxicity was assessed in 
a standard slCr release assay. Syn- 
geneic MC57G (H-2  b) fihroblasts 
infected with VSV were used as 
target cells, hCD4 +/-  mCD4 -/- 
(0pen circle); mCD4 -/-  (solid tri- 
angle); mCD4 + / + (solid diamond); 
unprimed  (solid square).  Specific 
lysis  of  noninfected  control 
MC57G  was  below  5%  for  all 
effectors shown. 
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Figure  7.  (A) Primary MLR.  Spleen cell responders were cocultured 
with irradiated splenic stimulators as described in Materials and Methods. 
Results depicted represent data from 7-d MLR cultures. Lymphocytes from 
hCD4 +/- DQw6 + / - mCD4/8- / - b/b mice were tolerant to DQw6 mol- 
ecules  as  compared  with  their  hCD4 +/-  mCD4/8-/-b/b  littermates 
which responded vigorously to DQw6. Both strains of mice were tolerant 
to hCD4 and to H-2  b syngeneic stimulator cells. Irradiated splenic stimu- 
lators: hCD4 +/-  DQw6 +/- mCD4/8-/-b/b  (solid black bar); hCD4 +/- 
mCD4/8 -/-  b/b (shaded bar); mCD4/8-/-b/b  (striped bar). (B) Anti- 
body blocking. Spleen cell responders from hCD4+mCD4/8-/-b/b  mice 
were cocultured with irradiated splenic stimulators from DQw6 + mCD4/ 
8-/-b/b  mice in the presence of anti-DQ (solid squares) or anti-I-A  b (open 
squares) control antibodies as described in Materials and Methods. Anti- 
DQ  monoclonal antibodies were able to block the T  cell response in a 
dose dependent fashion, whereas,  anti-l-A  b monoclonal antibodies were 
not. Plotted values represent the mean counts per minute of triplicate cul- 
tures in 96-well tissue culture plates with background counts substracted. 
Error bars represent standard deviation. Statistical analysis using paired Stu- 
dent's t test indicated that the differences shown were statistically significant 
(V <0.05). 
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Figure  8.  T  cell proliferative  responses to M6C2 peptide  antigen in 
hCD4+DQw6+mCD4/68 -/-  b/b (open square), and  hCD4+mCD4/ 
8-/-b/b (solid diamond) mice.  Mice were immunized with M6C2 pep- 
tide as described  in Materials  and Methods.  9-12 d later inguinal and 
paraaortic  lymph nodes were harvested.  Lymphocytes were enriched  for 
T cells, as described, and 4  x  10  s T cells put into culture with 8  x  10  s 
autologous T cell depleted, irradiated splenocytes with or without M6C2 
peptide.  T  cell  proliferation  was  measured  by  [JH]thymidine  uptake. 
Plotted values represent  the mean of triplicate  cultures  in 96-well tissue 
culture plates with background counts substracted. The experiment shown 
is representative  of seven experiments  involving immunization of three 
to four mice per group in each experiment.  Error bars represent  standard 
deviation. Statistical analysis using paired Student's  t test showed that the 
differences between experimental  groups  were statistically  significant  (p 
<0.05). 
mice did not show significant proliferation above baseline in 
the presence of the M6C2 peptide (data  not  shown). 
Discussion 
The  results  presented  here  demonstrate  the  appropriate 
reconstitution ofphenotype and function by the hCD4 and 
hDQw6 transgenes in mice which lack expression of endog- 
enous mCD4 and mCD8 molecules after targeted gene dis- 
ruption and homologous recombination in embryonic stem 
cells.  T  cell development in the thymus is rescued,  as evi- 
denced by the dramatic increase in size of the thymic medulla 
on serial histologic sections and reconstitution of the mature 
TCR-o~/~i~ig i~  thymocyte  population  on  flow  cytometric 
analysis.  The mature peripheral  T  cell population was also 
restored with the reemergence of normal numbers of TCR- 
ol/3 +  T  lymphocytes  in  lymph  nodes  and  spleen.  In 
mCD4-/-  single knockout mice, the peripheral T cell pool 
consists of a majority of CD8 + T  cells and few (10%)  of 
CD4-8-  o~/3 T  cells. The presence of the hCD4 molecule 
normalized the ratio of CD4/CD8 T cells by decreasing the 
number of CD8 § T  cells back to that in normal mice. The 
mCD8 + cells,  however, expressed low levels of hCD4 due 
to the CD2 expression cassette (Fig. 4 B). These data clearly 
show the  human  CD4  molecule functioned  as  a positive 
selecting element, interacting with endogenous mouse I-A  b 
molecule, rescuing T cell maturation in the mCD4/8-deficient 
mice. 
The human MHC class II molecule DQw6 functioned effec- 
tively in T  lymphocyte development resulting in mice that 
were unresponsive to DQw6 in MLR assay, indicating that 
the hCD4 and DQw6 molecules interact during T  cell de- 
velopment to induce T cell tolerance to self DQw6. Human 
CD4 recognition of DQw6 molecules was specific, as anti- 
DQ monoclonal antibodies were able to abolish reactivity 
to DQw6 in a dose-dependent fashion, whereas,  anti-hA h 
monoclonal  antibodies  were not  inhibitory.  Additionally, 
hCD4 interacted with mouse LA  b molecules resulting in T 
cell tolerance to routine self-MHC class II. It should be noted 
that mouse CD4 was also able to interact with the human 
DQw6 molecule, generating an effective T cell response to 
DQw6 in an MLR assay and induction of tolerance to DQw6 
during thymic development (19). Interestingly,  the kinetics 
of mCD4  and hCD4 interaction with DQw6 in MLR are 
similar and peak at day 7, as opposed to day 5 for MHC dis- 
cordant MLRs. It is well known that DQ antigens are weak 
alloantigens  (18),  which may account for this difference in 
response times. As previously published, mCD4/8-/-  mice 
have a weak but demonstrable alloreactivity (21). Consistent 
with  this  observation  was  the  low  T  cell  response  of 
mCD4/8 -/-  mice upon  DQw6 stimulation.  Appropriate 
tissue-specific expression of the DQw6 alleles comparable in 
distribution to that of mouse I-A  b molecules has previously 
been shown (19). DQw6 expression was found on the cortex 
and medulla of the thymus,  in lymph nodes,  spleen, bone 
marrow, skin,  and lungs,  and in APCs such as B cells, and 
rnacrophages, but was absent from liver, kidney, muscle, and 
uterus  (19). 
Most importantly, the DQw6 molecule functioned in an- 
tigen presentation,  as measured by specific T  cell prolifera- 
tive responses to M6C2, a 21-mer peptide derived from the 
M protein of rheumatogenic strains of Streptococcus. Thus, 
in this double transgenic knockout system, the DQw6 mol- 
ecule was functional in  antigen presentation,  generating  a 
human class II MHC-restricted T  cell response, suggesting 
that human CD4 functionally interacted with human MHC 
class  II molecules.  This  response is  specific  to  the  human 
DQw6 molecule as other DQ molecules,  such as,  DQw4 
are  unable  to  elicit  the  same  response  from  immunized 
DQw6 +  mice  (33).  Although  murine  CD4  can  interact 
with  human  MHC class  II molecules as detected by both 
MLR and T  cell responses to peptide presentation,  further 
analysis  of the human  CD4-human  MHC class II interac- 
tion vs. the interspecies mouse-human interactions  in the con- 
text of other antigens and superantigens  will enable us to 
dissect the nature of species-specific  molecular interactions. 
As previously reported (21), T help for B cells is markedly 
reduced but not completely absent in mice without CD4 alone 
1918  Human CD4-MHC Class II Transgenic Mice or in mice deficient in both CD4 and CD8 molecules. This 
residual T  help is provided by CD4 and CD8 double nega- 
tive  TCR-od~ +  T  cells,  which  are  restricted  to  class  II 
MHC molecules (29).  The level of T  help as measured in 
an in vivo assay was higher in the mCD4/8-/-  mice com- 
pared with the mCD4-/-  single knockout mice presumably 
due to the higher numbers of double negative cells in the 
periphery of the double knockout mice (29, 21). The hCD4 
transgene restored T  helper function for B cells, as demon- 
strated in immunoglobulin class switching from IgM to neu- 
tralizing  IgG  immunoglobulins  after VSV infection.  The 
hCD4 transgene also restored T help for CTL in the mCD4- 
deficient mice. After immunization  with VSV, the genera- 
tion of VSV-specific CTL responses,  which depend on T help 
(32),  returned  to normal  levels. 
Interestingly,  the expression level of human  CD4 varied 
inversely with the presence of mouse CD4 and CDS. Dra- 
matic increases in human CD4 surface expression occurred 
in the absence of both mouse CD4  and CD8 coreceptors, 
while a milder increase occurred in the absence of mouse CD4 
alone. In the hCD4+mCD4 -/-  single knockout mice, two 
T cell compartments exist, one with murine endogenous CD8 
and one without. The hCD4 transgene is expressed on both 
of these T cell subsets, and the level of hCD4 expression was 
dramatically higher in the CD8- T  cell compartment com- 
pared with the CD8 + cells (Fig.  4 B). The cytoplasmic do- 
main of CD4 is known to associate with the protein tyrosine 
kinase p56 lck (8, 34), and 79% homology exists between cy- 
toplasmic portions of human and murine CD4. The absence 
of murine CD4 and/or CD8 coreceptors may facilitate  the 
association of p56 lck with human CD4. P561Ck-mediated sig- 
naling has recently been shown to regulate the intensity of 
surface expression of the CD4 molecule in thymocytes (35). 
Thus we propose that  quantitative  or qualitatively altered 
hCD4/p56 lck interactions may stabilize surface expression of 
hCD4 accounting for the increased expression in knockout 
mice. Additionally, the high expression of hCD4 on T cells 
in the double knockout mice more closely models CD4 in- 
tensities on human  T  lymphocytes. 
Our results indicate that human CD4 and human MHC 
class II molecules are able to interact and effectively function 
in  mice,  reconstituting  phenotype  and  function  to  the 
CD4 +  T  helper  compartment  in  an  endogenous  mouse 
CD4 and CD8 deficient background. Both the human CD4 
and DQw6 molecules participated  in thymic development 
and T cell function in peripheral lymphoid organs.  The stable, 
long-term expression of both hCD4 and human MHC class 
II molecules in the absence of mCD4  and mCD8 provide 
a novel animal model to study the human CD4-MHC class 
II limb of the immune system during physiological iesponses 
and human disease. Various autoimmune diseases and super- 
antigen-mediated diseases have human MHC class II associa- 
tions.  The fact that human CD4 and MHC class II mole- 
cules can fully function in mice may also provide an animal 
model to study the pathogenic mechanisms of AIDS, because 
of the key role played by the hCD4 molecule as the receptor 
for gp120 (14),  and the  speculations  that  AIDS may be a 
superantigen-mediated  disease (36). This new system modeling 
the human CD4-MHC class II limb of the immune system 
in a knockout mouse background is a step towards recon- 
stituting a stably expressed human immune system in mice 
and may prove to be a powerful tool in dissecting human 
disease mechanisms. 
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